Amgen Has Relatively Smooth Sailing In Q2 Despite COVID-19 Headwinds

 
• By Mandy Jackson
  
Launch
COVID-19 makes for choppy waters, but Amgen sailed into second quarter growth
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business